Abstract
The whole-cell patch-clamp technique was used to analyze the effects of 5-hydroxytryptamine (5-HT) and alosetron on cultured myenteric neurons from newborn guinea pigs. All neurons responded to 5-HT (EC50 ∼ 38.7 μM) with a concentration-dependent inward current (reversal potential = 7.1 ± 1.7 mV) with a short latency and rapid decay. Because the 5-HT-induced inward current was mimicked by 2-methyl-5-hydroxytryptamine (50 μM) and blocked by ondansetron (5.0 μM) and MDL 72222 (0.05 μM), it was 5-HT3-mediated. Alosetron blocked (IC50 ∼ 0.05 μM; Hill coefficient ∼ 1.24) the 5-HT- and 2-methyl-5-hydroxytryptamine-induced inward currents. This effect was independent of membrane potential and was not seen when alosetron was delivered to the inside of cells. Alosetron-sensitive sites are, thus, accessible only on the ectodomain of the plasmalemma. The effect of alosetron was reversible, but not surmountable. Although nicotine (100 μM) mimicked the 5-HT-induced inward current, the response was antagonized by hexamethonium (100 μM), but not by alosetron, implying its potential to be a selective 5-HT3antagonist. Hexamethonium did not affect responses to 5-HT. Most neurons in the cultures were 5-HT-immunoreactive and immunostained with an antibody raised against 5-HT3 receptors. The 5-HT-selective uptake inhibitor, fluoxetine (30 μM), gradually reduced the amplitude of the current induced by 5-HT; the residual response was abolished by alosetron (0.2 μM). The effect of fluoxetine could have been caused by either the desensitization of 5-HT3 receptors or by a nonspecific 5-HT3antagonistic effect of fluoxetine. It is concluded that alosetron is a potent and noncompetitive 5-HT3 antagonist on myenteric neurons.
Footnotes
-
Send reprint requests to: Dr. Jin Zhai, Neuroscience Discovery Research, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Drop Code 0510, Indianapolis, IN 46285. E-mail:Jin_Zhai{at}Lilly.com
-
↵1 Supported by National Institutes of Health Grants NS27645, NS35951 (A.L.K.), and NS12969 and Glaxo Wellcome, Inc. (M.D.G.).
-
↵2 Present address: Neuroscience Discovery Research, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Drop Code 0510, Indianapolis, IN 46285.
-
↵3 Present address: Department of Physiology and Pharmacology, SUNY Health Science Center at Brooklyn, 450 Clarkson Avenue, Box 29, Brooklyn, NY 11203.
- Abbreviations:
- CNS
- central nervous system
- ENS
- enteric nervous system
- 5-HT
- 5-hydroxytryptamine
- IBS
- irritable bowel syndrome
- Received February 25, 1999.
- Accepted June 7, 1999.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|